121 related articles for article (PubMed ID: 3910730)
21. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
Pizzo PA; Hathorn JW; Hiemenz J; Browne M; Commers J; Cotton D; Gress J; Longo D; Marshall D; McKnight J
N Engl J Med; 1986 Aug; 315(9):552-8. PubMed ID: 3526155
[TBL] [Abstract][Full Text] [Related]
22. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
J Antimicrob Chemother; 1995 Jul; 36(1):185-200. PubMed ID: 8537265
[TBL] [Abstract][Full Text] [Related]
23. A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.
Perkkiö M; Hovi L; Rajantie J; Lanning M; Salmi T; Williams K; Mäkipernaa A; Ruuskanen O; Renkonen OV; Herva E
Scand J Infect Dis; 1990; 22(2):209-18. PubMed ID: 2192440
[TBL] [Abstract][Full Text] [Related]
24. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.
de Pauw B; Williams K; de Neeff J; Bothof T; de Witte T; Holdrinet R; Haanen C
Antimicrob Agents Chemother; 1985 Dec; 28(6):824-8. PubMed ID: 3909956
[TBL] [Abstract][Full Text] [Related]
25. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
[TBL] [Abstract][Full Text] [Related]
27. [Piperacillin combined with netilmicin and cloxacillin. Usefulness in the treatment of febrile episodes in neutropenic children].
Schaison G; Leverger G; Arlet G
Presse Med; 1986 Dec; 15(46):2345-6. PubMed ID: 2949283
[TBL] [Abstract][Full Text] [Related]
28. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
[TBL] [Abstract][Full Text] [Related]
29. [Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients].
de Pauw BE
Infection; 1987; 15 Suppl 4():S168-72. PubMed ID: 3312029
[TBL] [Abstract][Full Text] [Related]
30. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.
Fainstein V; Bodey GP; Elting L; Bolivar R; Keating MJ; McCredie KB; Valdivieso M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():101-10. PubMed ID: 6352612
[TBL] [Abstract][Full Text] [Related]
31. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
32. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
33. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever.
Bayston KF; Want S; Cohen J
Am J Med; 1989 Nov; 87(5A):269S-273S. PubMed ID: 2686428
[TBL] [Abstract][Full Text] [Related]
34. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
[TBL] [Abstract][Full Text] [Related]
35. Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
Smith GM; Leyland MJ; Farrell ID; Geddes AM
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():165-74. PubMed ID: 3468101
[TBL] [Abstract][Full Text] [Related]
36. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies.
Martino P; Venditti M; Petti MC; Mandelli F; Serra P
Infection; 1985; 13(3):125-9. PubMed ID: 3928495
[TBL] [Abstract][Full Text] [Related]
37. A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients.
Fauser AA; Lang E; Köchling G; Daschner FD
Infection; 1994; 22(4):271-5. PubMed ID: 8002087
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
[TBL] [Abstract][Full Text] [Related]
39. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of empirical antibiotic therapy with one of four beta-lactam antibiotics in combination with netilmicin in febrile neutropenic patients.
Sage R; Hann I; Prentice HG; Devereux S; Corringham R; Hoffbrand AV; Blacklock H; Stirling L; Guimaraes M; Trikka E
J Antimicrob Chemother; 1988 Aug; 22(2):237-47. PubMed ID: 3053555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
